JPMorgan to price callable reverse exchangeables linked to Gilead

By Angela McDaniels

Tacoma, Wash., Feb. 2 – JPMorgan Chase & Co. plans to price callable reverse exchangeable notes due Feb. 13, 2017 linked to the common stock of Gilead Sciences, Inc., according to a 424B2 filing with the Securities and Exchange Commission.

The coupon is expected to be at least 9.15% per year and will be set at pricing. Interest will be payable monthly.

The notes are callable at par on Feb. 6, 2017.

If the notes are not called, the payout at maturity will be par unless the final share price is less than the initial share price and the stock closes below the trigger price, 72% of the initial share price, on any day during the life of the notes, in which case the payout will be a number of Gilead Sciences shares equal to $1,000 divided by the initial share price or, at the issuer’s option, an amount in cash equal to the value of those shares.

J.P. Morgan Securities LLC is the agent.

The notes will price Feb. 5.

The Cusip number is 46625HQD5.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.